Interpace Biosciences, Inc.
IDXG
$1.98
-$0.01-0.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 71.46% | -32.65% | -75.14% | -57.47% | -58.23% |
| Total Receivables | -33.88% | -18.20% | 16.52% | 75.15% | 68.26% |
| Inventory | -8.01% | -9.51% | -20.96% | 4.77% | -1.30% |
| Prepaid Expenses | 18.13% | 32.43% | 9.45% | 2.58% | -9.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 23.26% | 58.14% | 47.37% | -8.33% |
| Total Current Assets | -15.91% | -17.82% | -6.51% | 23.77% | 13.02% |
|
|
|||||
| Total Current Assets | -15.91% | -17.82% | -6.51% | 23.77% | 13.02% |
| Net Property, Plant & Equipment | -11.23% | -0.80% | 0.91% | 4.25% | 12.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 47,228.89% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 128.76% | -14.27% | -4.91% | 19.37% | 12.78% |
|
|
|||||
| Total Accounts Payable | -40.75% | -17.05% | -29.02% | 27.15% | 7.45% |
| Total Accrued Expenses | -18.88% | -77.78% | -69.04% | -66.84% | 10.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -90.78% | -76.71% | -69.34% | -59.88% | -14.68% |
| Total Finance Division Other Current Liabilities | 3.55% | -4.13% | -11.52% | -19.76% | -32.08% |
| Total Other Current Liabilities | 3.55% | -4.13% | -11.52% | -19.76% | -32.08% |
| Total Current Liabilities | -51.93% | -68.33% | -62.43% | -54.26% | -7.18% |
|
|
|||||
| Total Current Liabilities | -51.93% | -68.33% | -62.43% | -54.26% | -7.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -36.43% | -27.33% | -24.26% | -20.53% | -19.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.85% | 5.70% | 5.42% | 4.85% | 4.89% |
| Total Liabilities | -32.54% | -51.03% | -46.79% | -43.63% | -23.10% |
|
|
|||||
| Common Stock & APIC | 0.01% | 24.62% | 24.67% | 24.70% | 24.75% |
| Retained Earnings | 10.44% | 4.48% | 4.60% | 5.66% | 2.77% |
| Treasury Stock & Other | -0.88% | -1.27% | -2.22% | -2.22% | -2.29% |
| Total Common Equity | 1,108.71% | 99.48% | 97.94% | 99.05% | 96.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,108.71% | 99.48% | 97.94% | 99.05% | 96.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,108.71% | 97.33% | 90.29% | 96.02% | 75.37% |
|
|
|||||